ArsenalBio

We’re a programmable clinical-stage cell therapy company focused on the realization of solid tumor cell therapies. Our purpose is very clear: defeat cancer.

[ArsenalBio @ArsenalBio]

CEO @KDrazan will join a panel tomorrow, March 4, 3:30-4:30pm, at #PMWC26, where they will discuss Gene Editing & Synthetic Biology for Therapy.

More: https://t.co/MTzG5sbVFo #Biotech #Oncology

[ArsenalBio @ArsenalBio]

Today at the Evolution Summit, ArsenalBio’s Farah Anwar will share insights on CAR-T cell therapy and its potential to redefine the future of personalized cancer treatment.

More here: https://t.co/P8OGpWHVmM #CancerResearch

[ArsenalBio @ArsenalBio]

This Wednesday, ArsenalBio’s Farah Anwar will join a panel of clinical trial experts to share strategies for balancing scientific rigor, operational efficiency, and the patient experience.

More on the webinar: https://t.co/Ztwa0U4vyZ #celltherapy #clinicaltrials

[ArsenalBio @ArsenalBio]

Heading to @AdTherapiesConf USA 2025 this week? Check out one of the sessions where Christopher Murriel will share insights on #celltherapy development. https://t.co/0lUy2GZUSD #adtherapies #cancerresearch

[ArsenalBio @ArsenalBio]

We’re gearing up for #SITC2025! We will share the latest research on our lead investigative cell therapy intended for mCRPC, CAR T cell therapy design, and our foundation model predicting targets for overcoming T cell exhaustion. Join us Nov 7–9: https://t.co/zdFBHCcMrz

[ArsenalBio @ArsenalBio]

We’re presenting at the @CAR_TCell Summit tomorrow on the development of our T cell therapy intended for metastatic prostate cancer and maintaining high potency in our development of cell therapy products. https://t.co/XdVBqwCjir

#CellTherapy #CancerResearch #ProstateCancer

[ArsenalBio @ArsenalBio]

We’re developing a CAR-T cell therapy as a potential treatment for metastatic prostate cancer, for which new and more effective treatments are urgently needed. Stay tuned as we advance this program toward the clinic. More: https://t.co/6CumKnINpg #ProstateCancer #CancerResearch

[ArsenalBio @ArsenalBio]

Join ArsenalBio scientist Sophia Phillips on July 17 at the Process Development for Cell Therapies Summit for a case study on overcoming process development challenges in solid tumor-targeting cell therapies. https://t.co/tUOMG4aOMH
#CellTherapy #DrugDevelopment

[ArsenalBio @ArsenalBio]

On July 15 at the Process Development for Cell Therapies Summit, ArsenalBio scientist Max Lee will present during a workshop focused on implementing cutting-edge technology with phase-appropriate strategies. https://t.co/nMTSFNtVeK
#CellTherapy #Drug Development

[ArsenalBio @ArsenalBio]

Thanks to @BiotechTV and @bradloncar for sitting down with our CEO, @KDrazan , M.D., to hear about the latest on our CAR T cell therapies specifically designed to overcome the challenges presented by solid tumors. Full video available here: https://t.co/LKg4v71w9t
#CancerResearch

[BiotechTV @BiotechTV]

𝐂𝐀𝐑-𝐓 𝐋𝐨𝐠𝐢𝐜-𝐆𝐚𝐭𝐢𝐧𝐠: @ArsenalBio CEO @KDrazan describes the idea of logic-gating, which might allow CAR-T therapies to work in solid tumors when targeting more than one antigen is needed.

Full interview: https://t.co/bwoA7KXBaA

[ArsenalBio @ArsenalBio]

CEO @KDrazan, MD, will join a distinguished panel at @sitc’s Biotech Strategic Meeting at the #NYSE on Friday. The panel will cover cell therapy inflection points and strategies for reaching capital efficiency and scientific value. https://t.co/UH8heisJQJ #SITC #cancer

[ArsenalBio @ArsenalBio]

We’re honored to have @KDrazan, MD, Co-founder, CEO, and Chairman of the Board, recognized as a winner in the EY Entrepreneur Of The Year® 2025 Bay Area program. https://t.co/LeBqrfSaE6 #EOYUS #EOYBAYAREA

[ArsenalBio @ArsenalBio]

Heading to Fully Connected 2025? Hear from ArsenalBio’s Sofia Panagiotopoulou as she presents “A T-cell foundation model for AI-powered target discovery and precision medicine” on June 18.

Learn more and view the full agenda: https://t.co/B7m0Yf7ID6

[ArsenalBio @ArsenalBio]

We’re proud to share that @KDrazan, MD, ArsenalBio’s Co-founder, CEO, and Chairman, has been recognized along with other inspiring business leaders as a finalist in the EY Entrepreneur Of The Year® 2025 Bay Area program. Learn more: https://t.co/L5puygD6FC
#EOYUS #EOYBAYAREA

[ArsenalBio @ArsenalBio]

Future scientists at work! Each year at ArsenalBio, we hold a Bring a Kid to Work Day, where young minds explore our labs and experience the wonders of #STEM. #BringYourKidToWorkDay #TakeYourChildToWorkDay

[ArsenalBio @ArsenalBio]

Our One Team value extends to our local community by helping our neighbors with a cleanup day. Happy Earth Day.

[ArsenalBio @ArsenalBio]

Next week at the @AACR Annual Meeting, we’ll share research on how our synthetic pathway activator (SPA) modules enhance the functional persistence of our CAR T cell therapies and prevent T cell exhaustion. https://t.co/ckEsDju66F #AACR25 #CancerResearch

[ArsenalBio @ArsenalBio]

ArsenalBio CSO @nickhaining recently spoke with @DrugDiscovNews about our multi-pronged approach of equipping T cells to defeat solid tumors. Check out the article, "Armoring up CAR T cells to fight solid tumors" at https://t.co/FHEET4xIk2 #CancerResearch #CellTherapy

[ArsenalBio @ArsenalBio]

It’s a busy week for ArsenalBio as we present at three scientific conferences: Supply Chain & Logistics for Cell & Gene Therapies Summit, Cell Therapy Potency Assay Summit, and SITC Spring Scientific Cellular Therapy for Solid Tumors. Details on the image.

[ArsenalBio @ArsenalBio]

Happy #EmployeeAppreciationDay to our 270 employees! We're so grateful for you and your many contributions toward our collective mission of defeating cancer. #CancerResearch #Biotech